跳至主要内容
临床试验/RBR-3rdhgm
RBR-3rdhgm招募中未知

The role of early acute renal support in the prognosis of patients diagnosed of COVID-19: a randomized clinical trial

Departamento de Clínica Médica da Faculdade de Medicina de Botucatu0 个研究点开始时间: 2020年5月14日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

入选标准

  • patients over 18 years old; COVID-19 positive by the RT-PCR technique or rapid test; in mechanical ventilation; diagnosis of AKI; hydric balance positive higher then 3% of body weight; hospitalized in the ICU;vusing norepinephrine at a dose of 0.1 to 1 µg / kg / min.

排除标准

  • Pregnant patients; patients who were on other types of dialysis support, other than HDP or HDC, that with an emergency indication for RAS; diagnosed with stage 5 chronic kidney disease or need for chronic renal replacement therapy (dialysis or transplantation) will be excluded.

研究者

发起方
Departamento de Clínica Médica da Faculdade de Medicina de Botucatu

相似试验